As pharma companies bolster their pipelines via multibillion-dollar acquisitions, drug manufacturers continue to heavily invest in the oncology space.
A U.S. Senate panel on Wednesday launched a bipartisan probe into pharmaceutical drug pricing, seeking documents from four drugmakers including Valeant Pharmaceuticals and Turing Pharmaceuticals, two companies embroiled in controversy […]
